36.84 USD
-0.84 (-2.23%)
36.84 USD
0 (0%)
Overall HRMY gets a fundamental rating of 8 out of 10. We evaluated HRMY against 190 industry peers in the Pharmaceuticals industry. HRMY gets an excellent profitability rating and is at the same time showing great financial health properties. HRMY is evaluated to be cheap and growing strongly. This does not happen too often! These ratings would make HRMY suitable for value and growth and quality investing!
1. Profitability
1.1 Basic Checks
- In the past year HRMY was profitable.
- In the past year HRMY had a positive cash flow from operations.
- Of the past 5 years HRMY 4 years were profitable.
- Of the past 5 years HRMY 4 years had a positive operating cash flow.
1.2 Ratios
- HRMY has a Return On Assets of 15.37%. This is amongst the best in the industry. HRMY outperforms 95.26% of its industry peers.
- The Return On Equity of HRMY (22.23%) is better than 92.63% of its industry peers.
- The Return On Invested Capital of HRMY (17.20%) is better than 94.74% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for HRMY is significantly above the industry average of 12.83%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 15.37% | ||
| ROE | 22.23% | ||
| ROIC | 17.2% |
ROA(3y)19.12%
ROA(5y)10.08%
ROE(3y)31.57%
ROE(5y)9.53%
ROIC(3y)18.27%
ROIC(5y)15.29%
1.3 Margins
- Looking at the Profit Margin, with a value of 22.48%, HRMY belongs to the top of the industry, outperforming 91.58% of the companies in the same industry.
- In the last couple of years the Profit Margin of HRMY has grown nicely.
- HRMY has a better Operating Margin (27.32%) than 93.16% of its industry peers.
- HRMY's Operating Margin has declined in the last couple of years.
- Looking at the Gross Margin, with a value of 77.70%, HRMY belongs to the top of the industry, outperforming 83.16% of the companies in the same industry.
- HRMY's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.32% | ||
| PM (TTM) | 22.48% | ||
| GM | 77.7% |
OM growth 3Y-2.32%
OM growth 5YN/A
PM growth 3Y21.57%
PM growth 5YN/A
GM growth 3Y-1.56%
GM growth 5Y1.26%
2. Health
2.1 Basic Checks
- HRMY has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- The number of shares outstanding for HRMY has been increased compared to 1 year ago.
- Compared to 5 years ago, HRMY has less shares outstanding
- Compared to 1 year ago, HRMY has an improved debt to assets ratio.
2.2 Solvency
- HRMY has an Altman-Z score of 5.56. This indicates that HRMY is financially healthy and has little risk of bankruptcy at the moment.
- With a decent Altman-Z score value of 5.56, HRMY is doing good in the industry, outperforming 75.26% of the companies in the same industry.
- The Debt to FCF ratio of HRMY is 0.57, which is an excellent value as it means it would take HRMY, only 0.57 years of fcf income to pay off all of its debts.
- Looking at the Debt to FCF ratio, with a value of 0.57, HRMY belongs to the top of the industry, outperforming 96.84% of the companies in the same industry.
- A Debt/Equity ratio of 0.18 indicates that HRMY is not too dependend on debt financing.
- HRMY's Debt to Equity ratio of 0.18 is in line compared to the rest of the industry. HRMY outperforms 46.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 0.57 | ||
| Altman-Z | 5.56 |
ROIC/WACC1.81
WACC9.49%
2.3 Liquidity
- A Current Ratio of 3.75 indicates that HRMY has no problem at all paying its short term obligations.
- HRMY has a Current ratio of 3.75. This is comparable to the rest of the industry: HRMY outperforms 57.89% of its industry peers.
- A Quick Ratio of 3.72 indicates that HRMY has no problem at all paying its short term obligations.
- HRMY's Quick ratio of 3.72 is in line compared to the rest of the industry. HRMY outperforms 58.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.75 | ||
| Quick Ratio | 3.72 |
3. Growth
3.1 Past
- HRMY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 50.71%, which is quite impressive.
- Measured over the past years, HRMY shows a very strong growth in Earnings Per Share. The EPS has been growing by 44.61% on average per year.
- The Revenue has grown by 21.13% in the past year. This is a very strong growth!
- Measured over the past years, HRMY shows a very strong growth in Revenue. The Revenue has been growing by 160.13% on average per year.
EPS 1Y (TTM)50.71%
EPS 3Y44.61%
EPS 5YN/A
EPS Q2Q%10.13%
Revenue 1Y (TTM)21.13%
Revenue growth 3Y32.77%
Revenue growth 5Y160.13%
Sales Q2Q%28.71%
3.2 Future
- HRMY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.10% yearly.
- HRMY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.79% yearly.
EPS Next Y30.39%
EPS Next 2Y29.73%
EPS Next 3Y25%
EPS Next 5Y35.1%
Revenue Next Year21.02%
Revenue Next 2Y18.62%
Revenue Next 3Y16.71%
Revenue Next 5Y14.79%
3.3 Evolution
- Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 11.58, the valuation of HRMY can be described as reasonable.
- Based on the Price/Earnings ratio, HRMY is valued cheaper than 88.95% of the companies in the same industry.
- The average S&P500 Price/Earnings ratio is at 28.60. HRMY is valued rather cheaply when compared to this.
- With a Price/Forward Earnings ratio of 8.72, the valuation of HRMY can be described as very reasonable.
- Based on the Price/Forward Earnings ratio, HRMY is valued cheaply inside the industry as 90.00% of the companies are valued more expensively.
- The average S&P500 Price/Forward Earnings ratio is at 25.83. HRMY is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.58 | ||
| Fwd PE | 8.72 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, HRMY is valued cheaply inside the industry as 94.21% of the companies are valued more expensively.
- 95.26% of the companies in the same industry are more expensive than HRMY, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.15 | ||
| EV/EBITDA | 6.58 |
4.3 Compensation for Growth
- HRMY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- The excellent profitability rating of HRMY may justify a higher PE ratio.
- A more expensive valuation may be justified as HRMY's earnings are expected to grow with 25.00% in the coming years.
PEG (NY)0.38
PEG (5Y)N/A
EPS Next 2Y29.73%
EPS Next 3Y25%
5. Dividend
5.1 Amount
- HRMY does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
HARMONY BIOSCIENCES HOLDINGS / HRMY FAQ
Can you provide the ChartMill fundamental rating for HARMONY BIOSCIENCES HOLDINGS?
ChartMill assigns a fundamental rating of 8 / 10 to HRMY.
What is the valuation status of HARMONY BIOSCIENCES HOLDINGS (HRMY) stock?
ChartMill assigns a valuation rating of 9 / 10 to HARMONY BIOSCIENCES HOLDINGS (HRMY). This can be considered as Undervalued.
Can you provide the profitability details for HARMONY BIOSCIENCES HOLDINGS?
HARMONY BIOSCIENCES HOLDINGS (HRMY) has a profitability rating of 8 / 10.
What are the PE and PB ratios of HARMONY BIOSCIENCES HOLDINGS (HRMY) stock?
The Price/Earnings (PE) ratio for HARMONY BIOSCIENCES HOLDINGS (HRMY) is 11.58 and the Price/Book (PB) ratio is 2.54.
What is the earnings growth outlook for HARMONY BIOSCIENCES HOLDINGS?
The Earnings per Share (EPS) of HARMONY BIOSCIENCES HOLDINGS (HRMY) is expected to grow by 30.39% in the next year.